Autolus Therapeutics PLC (NAS:AUTL)
$ 3.825 -0.015 (-0.39%) Market Cap: 1.02 Bil Enterprise Value: 314.39 Mil PE Ratio: 0 PB Ratio: 1.75 GF Score: 55/100

Autolus Therapeutics PLC to Summarize the ASH Data Transcript

Dec 12, 2022 / 03:30PM GMT
Release Date Price: $1.77 (-4.32%)
Operator

Hello, ladies and gentlemen. I am pleased to welcome you to Autolus Therapeutics ASH 2022 Investor Conference Call. As a reminder, this conference call is being recorded.

I would now like to turn the conference call over to your host, Olivia Manser, Director, Investor Relations. Please go ahead.

Olivia Manser
Autolus Therapeutics plc - Director of IR

Thanks, Justin. Hi, everyone, good afternoon or good morning, and thanks for joining us and taking part in today's call, in which we'll be covering the data we're presenting at the ASH conference. So this is Olivia. On the call, as usual, are Dr. Christian Itin, our Chief Executive Officer; and Dr. Lucinda Crabtree, our Chief Financial Officer.

So before we begin, as always, just to remind you that during today's call, our discussion will contain forward-looking statements and those are on Slide 2. So please make sure you're familiar with the disclaimer slide.

And with that, I'll hand over to Christian to summarize the data. And afterwards, we will welcome your questions. So over to

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot